GI CANCERS

Latest News

Immunotherapy Duo Shows 42% 2-Year Survival in MSS CRC Trial
Immunotherapy Duo Shows 42% 2-Year Survival in MSS CRC Trial

July 15th 2025

Agenus reveals promising survival rates for its immunotherapy in metastatic colorectal cancer, potentially transforming treatment for resistant patients.

FDA Grants Orphan Drug Status to STEAP1-Targeting ADC for Gastric Cancer
FDA Grants Orphan Drug Status to STEAP1-Targeting ADC for Gastric Cancer

July 9th 2025

FDA Grants Orphan Drug Designation to Liposomal Gemcitabine in Biliary Tract Cancer
FDA Grants Orphan Drug Designation to Liposomal Gemcitabine in Biliary Tract Cancer

July 8th 2025

FDA Approves SIR-Spheres Y-90 for First-Line Use in Unresectable HCC
FDA Approves SIR-Spheres Y-90 for First-Line Use in Unresectable HCC

July 7th 2025

Video Series
Video Interviews
Podcasts

More News